C81.3

Clinical Causes: The exact cause of lymphocyte depleted Hodgkin lymphoma remains unknown. Potential association with suppressed immune function, such as in individuals with HIV/AIDS. Genetic mutations may play a role in the development of this lymphoma subtype. History of prior cancer treatments that affect the immune system, including chemotherapy or radiation therapy. Some cases may be linked to viral infections, like Epstein-Barr virus (EBV), though less frequently than other subtypes.

Key Symptoms: Swollen lymph nodes, often in the neck, underarm, or groin. Constitutional symptoms, including fever, night sweats, and unexplained weight loss. Fatigue and weakness. Pain or discomfort in affected areas due to lymph node enlargement. Possible weight loss and loss of appetite. General malaise and symptoms related to immune suppression, such as increased infection risk.

Diagnosis Path: Diagnosis of lymphocyte depleted Hodgkin lymphoma involves a combination of medical history assessment, physical examinations, and laboratory tests. Key diagnostic procedures include: - Histopathological examination: A biopsy of affected lymph nodes reveals characteristic cellular features, notably numerous Reed-Sternberg cells with marked depletion of lymphocytes. - Immunohistochemistry: Helps identify specific markers that distinguish this subtype from other Hodgkin lymphomas. - Imaging studies: PET scans and CT scans assess the extent of disease spread. - Blood tests: Evaluate overall health and detect any signs of systemic involvement. Accurate classification relies on pathological and clinical data to ensure appropriate treatment planning.

Treatment Protocols: Treatment options for lymphocyte depleted Hodgkin lymphoma typically involve aggressive combination therapies, including: - Chemotherapy: Regimens like ABVD or escalated BEACOPP are commonly used. - Radiation therapy: May be applied to localized disease or residual tumors. - Targeted therapies and immunotherapies: Such as brentuximab vedotin or immune checkpoint inhibitors, especially in refractory cases. - Supportive care: Includes management of side effects, infection prevention, and nutritional support. The prognosis depends on disease stage and patient health, with aggressive treatment often needed due to the lymphoma's rapid progression.